Yim et al. demonstrated that Rak attenuates the binding of PTEN to NEDD4-1 by phosphorylating PTEN, thereby inhibiting its degradation and preserving its anti-tumorigenic effects on BC cells (Yim et al., 2009b). The gene discussed is NEDD4; the disease is breast cancer.